Neogenomics Inc (NASDAQ:NEO)

4.54
Delayed Data
As of Feb 27
 +0.13 / +2.95%
Today’s Change
2.95
Today|||52-Week Range
6.10
+8.87%
Year-to-Date

Today’s Trading

Previous close4.41
Today’s open4.42
Day’s range4.39 - 4.59
Volume235,859
Average volume (3 months)234,387
Market cap$272.3M
Dividend yield--
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)+2,976.92%
Earnings growth (this year)-79.17%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+11.02%
P/E ratio227.0
Price/Sales2.63
Price/Book10.27

Competitors

 Today’s
change
Today’s
% change
CPHRCipher Pharmaceutica...-1.43-11.05%
RDNTRadNet Inc+0.12+1.39%
NBSNeoStem Inc-0.07-1.83%
CTICCTi Biopharma Corp-0.04-1.68%
Data as of 3:59pm ET, 02/27/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$66.5M
Annual profit (last year)$2.0M
Net profit margin3.06%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. VanOort
Chief Operating Officer
Robert J. Shovlin
Corporate headquarters
Fort Myers, Florida

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account